Skip to content

Clinical trials

Phase 1/2 Astrocytoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Astrocytoma Phase: Phase 1/2 Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20016
20023
20043
20055
20062
20072
20083
20093
20107
20113
20123
20133
20161
20174
20183
20211
20224
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated11
Recruiting10
Unknown status3
Withdrawn2
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
New Approaches to Brain Tumor Therapy Consortium7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Duke University4
Northwell Health3
INSYS Therapeutics Inc2
M.D. Anderson Cancer Center2
St. Jude Children's Research Hospital2
Abramson Cancer Center at Penn Medicine1
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Astrocytoma74
Glioblastoma60
Oligodendroglioma41
Brain Neoplasms38
Glioma37
Gliosarcoma37
Central Nervous System Neoplasms29
Medulloblastoma7
Ependymoma6
Diffuse Intrinsic Pontine Glioma5

Trials

Showing 51 to 74 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.